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Summary In this study the role of adenosine A1 and A2A receptors of the hippo-
campal CA1 region on piriform cortex-kindled seizures was investigated in rats.
Animals were kindled by daily electrical stimulation of piriform cortex. In fully
kindled rats, N6-cyclohexyladenosine (CHA; a selective A1 receptor agonist), 1,3-
dimethyl-8-cyclopenthylxanthine (CPT; a selective A1 receptor antagonist), CGS21680
hydrochloride (CGS, a selective A2A receptor agonist) and, ZM241385 (ZM, a selective
A2A receptor antagonist) were microinfused bilaterally into the hippocampal CA1
region. Rats were stimulated and seizure parameters were measured. Obtained
results showed that microinjection of CHA (10 and 100 mM) decreased the after-
discharge duration (ADD), stage 5 seizure duration (S5D) and seizure duration (SD),
and significantly increased the latency to stage 4 (S4L). Intra-hippocampal CPT
increased ADD at the dose of 20 mM. Pretreatment of rats with CPT (10 mM) before
CHA (10 mM), significantly reduced the effect of CHA on seizure parameters. On the
other hand, microinjection of CGS (200 and 500 mM) increased ADD, but of ZM had no
effect on seizure parameters. Pretreatment of rats with ZM (50 mM) before CGS
(500 mM), significantly reduced the effect of CGS on seizure parameters. The results
suggest that the facilitatory role of the hippocampal CA1 region in relaying or
spreading of piriform cortex kindled seizures is decreased by the activation of
adenosine A1 receptors and increased by A2A receptors.
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Of the various epileptic syndromes, temporal lobe
epilepsy (TLE) is the most common disorder in. Published by Elsevier Ltd. All rights reserved.
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The kindling model has been most often used to
study TLE and seizure propagation (e.g. 2). In the
kindling, administration of low-intensity daily
electrical stimulation to a forebrain site initially
produces only a brief electrographic discharge.
With repeated stimulations, seizure discharges
grow progressively in duration and complexity, and
eventually trigger convulsive motor responses.3
Among different brain regions the piriform cortex
(PC) and hippocampus are recognized as two most
important structures involved in the development
and control of kindled seizures.4,5 These two struc-
tures are heavily interconnected by reciprocal path-
ways and the existence of functional interactions
have been demonstrated.6,7 Thus, limbic and/or
kindled seizure activity can spread in hippocam-
pus/PC circuit.4
One of the most characteristic changes occurring
during kindling is the increased propagation of the
seizure discharge from the site of stimulation, e.g.
PC, to the other sites, such as hippocampus, and the
recruitment of those sites into the discharge.2 In this
regard, it may be postulated that neurotransmitters
and/or neuromodulators which can affect the
neural activity of the hippocampus, may also alter
the seizures elicited from the PC. The precise role of
these agents remains to be determined.
Adenosine is commonly accepted as a neuromo-
dulator in the CNS,8,9 and has been considered as
an endogenous anticonvulsant agent,10,11 This pur-
ine base and its analogues have been shown to be
potent anticonvulsants in different seizure mod-
els10,12,13 and the levels of endogenous adenosine
are dramatically elevated in the brain following
seizures.14 As the main anticonvulsant effects of
adenosine are exerted through A1 receptors,
10,15 it
has been suggested that microinjection of selec-
tive A1 receptor agonists into the regions contain-
ing these receptors, should suppress kindled
seizures elicited from other brain regions. How-
ever, we recently showed that intra-amygdala
microinjection of adenosine A1 receptor agonist
had no effect on seizures elicited from entorhinal16
or PC (unpublished data). In addition, there are
controversial results about the role of adenosine
A2A receptors in kindled seizures.
17—19
Therefore, considering the anatomical connec-
tion between the hippocampus and PC, and the
existence of adenosine A1 and A2A receptors in the
hippocampal CA1 region,13,20 in this study we tried
to determine the effects of microinjection of
adenosine A1 and A2A receptor agonists and
antagonists into the hippocampal CA1 region on
kindled seizures elicited by electrical stimulation
of PC.Materials and methods
Animals
Ninety-eight male Sprague—Dawley rats weighing
300—350 g were housed under 12-h light/12-h dark
conditions with ad libitum access to food and
water. Procedures involving animals and their care
were conducted in accordance with the NIH guide-
lines for the care and use of laboratory animals. All
experiments were done between 9.00 and 12.00
o’clock in the morning to avoid the bias of circa-
dian rhythms.
Surgical and kindling procedure
For stereotaxic surgery, the rats were anesthetized
with a combination of ketamine (100 mg/kg, i.p.)
and xylazine (12 mg/kg, i.p.). Animals were
implanted with bipolar stimulating and monopolar
recording electrodes (twisted into a tripolar config-
uration) terminating in the PC (coordinates: A,
+0.2 mm; L, 4.8 mm; and 7.6 mm below dura) of
the right hemisphere. Two 22-gauge guide cannulae
were also implanted in the right and left dorsal
hippocampal CA1 regions (coordinates: A,
3.6 mm; L: 2.3 mm and 2.1 mm below dura).21
Electrodes (stainless steel, teflon-coated, 127 mm in
diameter, AM-Systems, USA) were insulated except
at the cross section of their tips. Two other electro-
des were connected to skull screws, placed above
the left skull surface as ground and differential
electrodes.
One week after surgery, afterdischarge (AD)
threshold was determined in PC by a 2 s, 60 Hz
monophasic square wave stimulus of 1 ms per wave.
The stimulations were initially delivered at 10 mA
and then at 5 min intervals increasing stimulus
intensity in increments of 10 mA until at least 5 s
of ADs were recorded as previously described.22 The
animals were then stimulated daily at the AD thresh-
old intensity until five consecutive stage 5 seizures
(according to the Racine23) were elicited. The
recorded parameters were: AD duration (ADD),
the latency to the onset of stage 4 seizure (S4L),
stage 5 seizure duration (S5D), total seizure dura-
tion (SD) and seizure stage (SS).
Drug administration
N6-cyclohexyladenosine (CHA; Sigma, UK), a selec-
tive A1 receptor agonist, 1,3-dimethyl-8-cylclo-
penthylxanthine (CPT; RBI, USA), a selective A1
receptor antagonist and CGS21680-hydrochloride
(CGS; Sigma, UK), a selective A2A receptor agonist
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(in mM): 114 NaCl, 1.25 NaH2PO4, 2 MgSO4,
26NaHCO3, 1 CaCl2 and 10 glucose]. ZM241385
(Tocris Cookson, UK), a selective A2A receptor
antagonist was dissolved in DMSO and then diluted
in ACSF to the desired concentration. pH of solutions
was adjusted to 7.3—7.4 using 1N NaOH. The solu-
tions were then sterilized through microfilters
(0.2 mm, Minisart, NML, Sartorius, Germany). Drugs
were infused bilaterally (1 ml over 2 min) via a 27-
gauge cannula, which was 1 mm below the tip of 22-
gauge cannula. A different group of rats was used for
each of the drug doses employed and for the dif-
ferent time intervals after drug infusion. Most of the
rats received only one dose of drug and stimulated
at one time. However, some rats were administered
the second dose. In these cases, the time interval
between two doses was at least 2 weeks. At least six
rats were used in each group. The drug dosages and
the stimulation time post-infusion were choiced
according to our previous studies.16,22
Microinjection of A1 receptors agonist or
antagonist
In different groups of fully kindled rats, CHA (0.1, 1,
10 and 100 mM) or CPT (10 and 20 mM) was micro-
injected into the hippocampal CA1 region. Five, 15
and 90 min after the injection, rats were stimulated
at AD threshold. In other groups of rats, the effect of
intra-hippocampal CPT pretreatment upon admin-
istration of CHA was investigated. CPT (10 mM) was
microinjected 5 min before CHA (10 mM) and rats
were stimulated at 5, 15 and 90 min after the
agonist treatment. In each case, 24 h prior to the
experiment, rats received ACSF, were stimulated in
the samemanner and the results recorded as control
values.
Microinjection of A2A receptors agonist or
antagonist
Different groups of fully kindled rats received CGS
(10, 200 and 500 mM) or ZM (50 and 100 mM).
Because the most significant effects of A1 receptor
agonist were observed at 15 min post-infusion, rats
were only stimulated at this time. In another
group, the effect of intra-hippocampal ZM upon
CGS was investigated. ZM (50 mM) was microin-
jected 5 min before CGS (500 mM) and the rats were
stimulated 15 min after the agonist treatment.
In each case, 24 h prior to the experiment, rats
received appropriate vehicle, were stimulated in
the same manner and the results recorded as con-
trol values.Histology
Electrode and cannula locations were determined at
the end of procedure. Each animal was deeply
anesthetized with urethane and sacrificed by perfu-
sion-fixation with 10% paraformaldehyde by gravity
feed through the left ventricle for 15 min. The
brains were removed and sectioned on a vibratome.
Coronal sections were cut 100 mm thick and exam-
ined under microscope for electrode and cannula
positions and the presence of any tissue damage. In
case of any abnormality, the data from that parti-
cular animal were not included in the results.
Statistical analysis
Results obtained are expressed as the mean-
s  S.E.M. and accompanied by the number of
observations. A two-way ANOVA was done to com-
pare different groups of animals at different times
post-different doses of A1 agonist and antagonist
injections. Also, one-way ANOVA was done to com-
pare different groups of animals at different doses
of A2A agonist or antagonist injections. Comparison
of data from animals receiving a drug with their
respective control was carried out by paired Stu-
dent’s t-test. However, comparison of normalized
data (as % of control) was carried out by Wilcoxon’s
test. A P-value of less than 0.05 was considered to
represent a significant difference.Results
All kindled rats responded to electrical stimulation
with stable stage 5 seizures in either no infused
condition or after vehicle infusion. Infused vehicles
didn’t produce any significant changes in seizure
parameters. At the doses employed, drugs did not
exert any noticeable effect on behavioral or loco-
motor activity. Histological assessment indicated
that the electrodes and infusion cannulae were
positioned in the PC and CA1 region of the hippo-
campus. As mentioned before, some rats were admi-
nistered the second dose. These particular rats did
not represent the outliers of the measured para-
meters and were equally divided over the different
treatment groups.
Effects of intra-hippocampal A1 receptors
agonist or antagonist
The inhibitory effects of CHA on seizure parameters
were evident 5 min after drug infusion. All the
measured parameters had returned to normal
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Figure 1 Effect of intra-hippocampal CHA (1,10 and
100 mM) on afterdischarge duration of PC kindled rats
at different time points post-drug microinjection (n = 6).
Values aremean  S.E.M., **P < 0.01 and ***P < 0.001 when
compared to ACSF treated animals by two-tailed paired
t-test.
Figure 2 Effect of intra-hippocampal CHA (10 and 100 mM)
seizure duration (right) of PC kindled rats at different time
 S.E.M., *P < 0.05 and ***P < 0.001 when compared to ACSFvalues (baseline) at 90 min post-drug administration
and thus the observed effects could not be related
to tissue damage. Different doses of drugs had no
significant effects on seizure stage at different time
points post-infusion. Intra-hippocampal CHA (1—
100 mM) led to significant decrease in the duration
of afterdischarges generated from the piriform cor-
tex after electrical stimulation (Fig. 1). The
decreasing effect was evident in the groups, which
were stimulated 15 min after drug injection. A two-
way ANOVA of resultant data revealed significant
effect of dose, time or interaction of time  dose
(P < 0.001).
Likewise, intra-hippocampal infusion of CHA (10
and 100 mM) resulted in the prolongation of latency
to the onset of forelimb clonus (S4L; Fig. 2). The
two-way ANOVA showed no significant effect of dose
(P = 0.17), time (P = 0.30) or interaction of time -
 dose (P = 0.28). In addition, CHA reduced the
duration of stage 5 (S5D; Fig. 2) and seizure (SD;
Fig. 2) after intra-hippocampal administration at
the doses of 10 and 100 mM. Here, there was sig-
nificant effect of dose (P < 0.05) and time
(P < 0.001 for S5D and P < 0.01 for SD), and inter-
action of time  dose (P < 0.05).
Bilateral microinjection of CPT into the CA1
region of the hippocampus increased ADD and S5D
at the dose of 20 mM significantly (Fig. 3); but, had
no effect on seizure parameters at the dose of
10 mM. However, pretreatment (5 min) of rats with
CPT (10 mM) significantly attenuated the inhibitory
effect of CHA (10 mM) on seizure activity. As shown
in Fig. 4, in these groups, there was no significant
difference on seizure parameters with respect to
their related controls.on stage 4 latency (left), stage 5 duration (middle) and
points post-drug microinjection (n = 6). Values are mean
treated animals by two-tailed paired t-test.
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Figure 3 Effect of intra-hippocampal CPT (20 mM) on
afterdischarge duration (ADD) and stage 5 duration (S5D)
of PC kindled rats at different time points post-drug
microinjection (n = 6). Values are mean  S.E.M.,
*P < 0.05 and **P < 0.01 when compared to ACSF treated
animals by two-tailed paired t-test.
Figure 4 Effect of CPT pretreatment on reduction
effects of CHA on afterdischarge duration (ADD), stage
5 duration (S5D) and seizure duration (SD) and on incre-
ment effects of CHA on stage 4 latency (S4L). CPT (10 mM)
was microinjected 5 min before CHA (10 mM) (n = 6).
Values are mean  S.E.M., *P < 0.05 when compared to
control (100%) using Wilcoxon test.Effects of intra-hippocampal A2A receptors
agonist or antagonist
Intra-hippocampal microinjection of CGS at the
doses of 200 and 500 mM significantly increased
the afterdischarge duration (ADD, Fig. 5A), but,
had no effects on S4L, S5D and SD. In addition, no
change was observed at the dose of 10 mM. The one-
way ANOVA showed no significant effect of dose
(P = 0.053). Bilateral microinjection of ZM into the
CA1 region of hippocampus at the doses of 50 and
100 mM had no effect on seizure parameters.
However, pretreatment of rats with ZM (50 mM)
before CGS (500 mM), significantly attenuated the
CGS excitatory effect on ADD. As shown in Fig. 5B, in
this group, there was no significant difference in
ADD with respect to related control.
Discussion
Results of the present study showed that in the PC
kindled rats, activation of hippocampal A1 receptors
has anticonvulsant but of A2A receptors has procon-
vulsant effects on PC kindled seizures.
CHA is a selective adenosine A1 receptor ago-
nist24 and there are several studies showing its
anticonvulsant effects in different models of epi-
lepsy including kindling.10,16,22,25 However, to our
knowledge there have been few studies on the role
of various brain regions in exerting this effect.
We have recently shown that intra-amygdalamicroinjection of CHA has no anticonvulsant effect
on kindled seizures elicited from electrical stimu-
lation of entorhinal16 or piriform cortices (unpub-
lished data). In addition, our previous study
showed that intra-amygdala CHA (up to 1 mM)
had no significant effect on hippocampal (CA1)
kindled seizure parameters with the exception of
secondary ADs.22 Thus, to provide an overall view
about the anticonvulsant action of adenosine, it is
of importance to determine the exact role of A1
receptors of different brain regions on kindled
seizures.
It has been shown that there is a high concentra-
tion of adenosine A1 receptors in the CA1 region of
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Figure 5 (A) Effect of intra-hippocampal CGS (10, 200
and 500 mM) on afterdischarge duration (ADD) of PC
kindled rats at 15 min post-drug microinjection (n = 14).
(B) Effect of ZM pretreatment on increment effect of CGS
on afterdischarge duration. ZM (50 mM) was microinjected
5 min before CGS (500 mM) (n = 6). Values are mean
 S.E.M., *P < 0.05 when compared to ACSF 0treated
animals by two-tailed paired t-test.the hippocampus13 and application of A1 receptor
agonists have suppressive effects on hippocampal
neuronal activity.15,26—28 In this regard, the study
from Lee et al.29 gave the first evidence for the role
of the CA1 region in mediating the anticonvulsant
effect of endogenous adenosine. Thus, it may be
concluded that in our study, intra-hippocampal
injection of CHA could suppress neuronal activity
of this region and the observed anticonvulsant
action of CHA can be related to this suppression.
Also, it can reinforce the idea that, the hippocam-
pus could contribute to the excitatory mechanisms
that underlie the propagation of kindled seizures
from the PC.4
Comparing the effect of intra-hippocampal
microinjection of CHA on PC- with amygdala-kindled
seizures25 shows that lower concentration of CHA
(0.1 mM) is needed to produce a significant antic-
onvulsant effect on amygdala kindling. It shows that
activity of CA1 neurons is more effective on seizure
propagation from amygdala than PC.
In the present study, intra-hippocampal injec-
tion of CHA significantly reduced the duration of
ADs recorded from the PC, in a dose dependent
manner. It means that inhibition of neural activity
in the hippocampus by CHA can decrease the
neural activity of the PC as well. The S4L was also
increased by CHA. This parameter is an index ofgeneralized seizure at its start and its increase
reveals that hippocampus may play a role in
spreading of epileptic spikes from PC to other brain
region(s) and/or relaying of these spikes. Decrease
of S5D and SD is also another sign of CHA antic-
onvulsant action. Changes in S4L are because of
changes in the duration of seizure stages 1—3.
Because the reduction of SD is accompanied with
a decrease in S5D and an increase in S4L, it may be
concluded that both partial (1—3) and generalized
(4 and 5) stages of seizure can be affected by CHA.
All of these effects were antagonized by CPT,
which confirms that in our experiments, the antic-
onvulsant effects of CHA were mediated through
activation of A1 receptors.
The anticonvulsant effects of CHA were evident
at 5 and 15 min post-infusion. In our previous
report [25], we showed that a lipid insoluble
dye (pontamine sky blue) was spread within
0.8 mm diameters at 5 min and 1.2 mm diameter
at 15 min after microinjection (1 ml/2 min) and
thus, was restricted to the site of injection. As
CHA has low lipid solubility, its effects can be
attributed to the activation of A1 receptors at
the injected site (CA1). At the time of 90 min
post-injection no drug had any effects probably
because of diffusion.
A further finding of this study is that CGS, a
selective A2A receptor agonist,
30 exerts a procon-
vulsant effect 15 min post-infusion (which is too
short to diffuse to other brain areas). This
effect was antagonized by ZM (a selective A2A
receptor antagonist31) pretreatment, so, it is a
receptor dependent effect. Our results are among
the first report about the proconvulsive effect
of adenosine A2A receptors in kindled seizures
and are consistence with the observation that
A2A receptor agonist induced clonic and tonic sei-
zures following the application of a subconvulsant
audiogenic stimulus.18 In addition, we also
observed that intra-entorhinal cortex microinjec-
tion of CGS (1 mM) had a proconulsive effect on PC
kindled seizures and significantly increased ADD
(unpublished data). However, these are in contrast
with previous studies which showed that selective
A2A receptor agonist dose-dependently reduced
pentylenetetrazole-induced convulsions1 and
audiogenic seizures in DBA/2 mice18 and rats.19
Of course, it has been previously suggested that
activation of A1 receptors may be account for the
anticonvulsant activity of CGS.32 Meanwhile, some
investigators showed that the activation of A2A
receptors does not exert any anticonvulsant
effects.33,34
In addition, some investigators showed a
decrease in adenosine A2A mRNA and receptor bind-
Adenosine A1 and A2A receptors of hippocampal 47ing in striatum and no change in the hippocampus of
hippocampal-kindled rats;35 but, recently Rebola
et al.36 have shown that the binding density of
the A2A receptor antagonist and A2A receptor immu-
noreactivity increased in cortical membranes from
kindled rats. They conclude that after convulsive
behavior there is a long-term increased density of
A2A receptors, suggesting that A2A antagonists may
be promising anticonvulsive drugs. This confirms the
proconvulsive role of A2A receptors, which was
observed in our experiments. Thus, there are con-
troversies about the exact role of A2A receptors on
control of seizures.
It has been shown that A2A receptors activation
results in a facilitation of neurotransmitter
release.37—39 The search of these A2A receptors
has given rise to the idea that they mostly act to
fine-tune other neuromodulatory systems40 and,
among others, to control the tonic inhibitory
action of A1 receptors.
38 Thus, it has been sug-
gested that the control by adenosine of neuro-
transmitter release should be considered as a
balance between inhibitory A1 and facilitatory
A2A receptor-mediated actions.
37 Consistent with
this idea, our previous studies showed that intra-
hippocampal microinjection of a selective A1 ago-
nist (CHA) reduced amygdala kindled seizures,25
but of a nonselective A1 and A2A agonist (2-chlor-
oadenosine) had no significant effect on seizure
parameters.41
On the other hand, it has been shown that CGS
decreases the binding affinity of a selective A1
agonist42 and attenuates the ability of the A1 agonist
to inhibit the neural activity in the hippocampus.20
Thus, it is postulated that CGS effects may be partly
exerted through its interaction with A1 receptors.
However, the precise interaction between A1 and
A2A receptors in kindled seizures remains to be
investigated.
In our experiments, CPT increased seizure para-
meters. Although it is in contrast with our previous
research,16,22,25 this effect has been shown
in many other brain areas in vivo10,43 and in
vitro.44 However, ZM could not produce any
change in seizure parameters. Therefore, we
can consider the anticonvulsant role for endogen-
ous adenosine of the hippocampal CA1 in PC
kindled seizures, which is exerted through A1
but not A2A receptors.
On the basis of obtained results, it may be con-
cluded that activation of A1 and A2A receptors of the
hippocampal CA1 region has opposite effects on PC
kindled seizures. Further work is warranted to
determine the role of A1 and A2A receptors of dif-
ferent brain structures and their interactions in
kindled seizures.Acknowledgment
We thank Dr. Mohsin Raza Haidary for assistance with
English editing of the manuscript.References
1. French JA, Williamson PD, Thadani VM, Darcey TM, Mattson
RH, Spencer SS, Spencer DD. Characteristics of medial tem-
poral lobe epilepsy. I. Results of history and physical exam-
ination. Ann Neurol 1993;34:774—80.
2. Sato M, Racine RJ, Mclntyre DC. Kindling: basic mechanisms
and clinical validity. Electroencephalogr Clin Neurophysiol
1990;76:459—72.
3. Goddard GV, Mclntyre DC, Leech CK. A permanent change in
brain function resulting from daily electrical stimulation. Exp
Neurol 1969;25:295—330.
4. Loescher W, Ebert U. The role of the piriform cortex in
kindling. Prog Neurobiol 1996;50:427—81.
5. Mclntyre DC, Kelly ME. Is the pyriform cortex important for
limbic kindling? In: Wada JA, editor. Kindling 4. New York:
Plenum Press; 1990. p. 21—32.
6. Amaral DG, Witter MP. Hippocampal formation. In: Paxinos G,
editor. The rat nervous system. 2nd ed. San Diego: Academic
Press; 1995. p. 183—214.
7. Luskin MB, Price JL. The topographic organization of associa-
tional fibers of the olfactory system in the rat, including
centrifugal fibers to the olfactory bulb. J Comp Neurol
1983;216:264—91.
8. Haas HL, Selbach O. Functions of neuronal adenosine recep-
tors. Naunyn-Schmiedeberg’s Arch Pharmacol 2000;362:
375—81.
9. Jarvis M, Williams M. Adenosine in the central nervous sys-
tem. In: Williams M, editor. Adenosine and adenosine recep-
tors. Totowa: Humana Press; 1990. p. 423—60.
10. Dragunow M. Purinergic mechanisms in epilepsy. Prog Neu-
robiol 1988;31:85—108.
11. Dragunow M. Adenosine: the brain’s natural anticonvulsant.
Trends Pharmacol Sci 1986;7:128—30.
12. Barraco RA, Swanson TH, Phillis JW, Berman RF. Anticonvul-
sant effects of adenosine analogs on amygdaloid-kindled
seizures in rats. Neurosci Lett 1984;46:317—22.
13. Chen Y, Graham DI, Stone TW. Release of endogenous
adenosine and its metabolites by the action of NMDA
receptors in the rat hippocampus in vivo. Br J Pharmacol
1992;106:632—8.
14. Chin JH. Adenosine receptors in brain: neuromodulation and
role in epilepsy. Ann Neurol 1989;26:695—8.
15. Dunwiddie TV. Endogenously released adenosine regulated
excitability in the in vitro hippocampus. Epilepsia 1980;
21:541—8.
16. Mohammad-Zadeh M, Amini A, Mirnajafi-Zadeh J, Fathollahi
Y. The role of adenosine A1 receptors in the interaction
between amygdala and entorhinal cortex of kindled rats.
Epilepsy Res 2005. in press.
17. Adami M, Bertorelli R, Ferri N, Foddi MC, Ongini E. Effects of
repeated administration of selective adenosine A1 and A2A
receptor agonists on pentylenetetrazole-induced convulsions
in the rat. Eur J Pharmacol 1995;294:383—9.
18. De Sarro G, De Sarro A, Di Paola ED, Bertorelli R. Effects of
adenosine receptor agonists and antagonists on audiogenic
seizure-sensible DBA/2 mice. Eur J Pharmacol 1999;
371:137—45.
48 M. Zeraati et al.19. Huber A, Guttinger M, Mohler H, Boison D. Seizure suppres-
sion by adenosine A2A receptor activation in a rat model of
audiogenic brainstem epilepsy. Neurosci Lett 2002;329:289—
92.
20. Cunha RA, Johansson B, van der Ploeg I, Sebastiao AM, Ribeiro
JA, Fredholm BB. Evidence for functionally important ade-
nosine A2A receptors in the rat hippocampus. Brain Res
1994;649:208—16.
21. Paxinos G, Watson C. The rat brain in stereotaxic coordi-
nates. New York: Academic Press; 1986.
22. Mirnajafi-Zadeh J, Fathollahi Y, Pourgholami MH. Intraper-
itoneal and intraamygdala N6-cyclohexyladenosine suppress
hippocampal kindled seizures in rats. Brain Res 2000;
858:48—54.
23. Racine RJ. Modulation of seizure activity by electrical sti-
mulation 2. Motor seizure. Electroencephalogr Clin Neuro-
physiol 1972;32:281—94.
24. Jacobson KA, Van Golen PJM, William M. Adenosine recep-
tors: pharmacology, structure activity relationships and ther-
apeutic potential. Med Chem 1992;35:407—22.
25. Alasvand Zarasvand M, Mirnajafi-Zadeh J, Fathollahi Y, Paliz-
van MR. Anticonvulsant effect of bilateral injection of N6-
cyclohexyladenosine into the CA1 region of the hippocampus
in amygdala-kindled rats. Epilepsy Res 2001;47:141—9.
26. Corradetti R, Conte GL, Moroni F, Passiani MB, Pepeu G.
Adenosine decreases aspartate and glutamate release from
rat hippocampal slices. Eur J Pharmacol 1984;104:19—26.
27. Thompson SM, Hass HL, Gahvailer BH. Comparison of the
action of adenosine at pre and post synaptic receptors in the
hippocampus in vitro. J Physiol Lond 1992;451:347—63.
28. Wu LG, Saggau P. Adenosine inhibits evoked synaptic trans-
mission primarily by reducing pre synaptic calcium influx in
area CA1 of the hippocampus. Neuron 1994;12:1139—48.
29. Lee KS, Schubert P, Heinemann U. The anticonvulsive action
of adenosine: a postsynaptic, dendritic action by a possible
endogenous anticonvulsant. Brain Res 1984;321:160—4.
30. Lupica CR, CassWA, Zahniser NR, Dunwiddie TV. Effects of the
selective adenosine A2 receptor agonist CGS 21680 on in vitro
electrophysiology, cAMP formation and dopamine release in
rat hippocampus and striatum. J Pharmacol Exp Therap
1990;252:1134—41.
31. Cunha RA, Constantino MD, Ribeiro JA. ZM241385 is an
antagonist of the facilitatory responses produced by the
A2A adenosine receptor agonists CGS21680 and HENECA in
the rat hippocampus. Br J Pharmacol 1997;122:1279—84.32. Zhang G, Franklin PH, Murray TF. Activation of adenosine A1
receptors underlies anticonvulsant effect of CGS21680. Eur J
Pharmacol 1994;255:239—43.
33. Janusz CA, Berman RF. The A2 selective adenosine analog
CGS21680 depresses locomotor activity but dose not block
amygdala kindled seizures in rats. Neurosci Lett
1992;14:247—50.
34. Young D, Dragunow M. Status epilepticus may be caused by
loss of adenosine anticonvulsant mechanism. Neuroscience
1994;58:245—61.
35. Aden U, O’Connor WT, Berman RF. Changes in purine levels
and adenosine receptors in kindled seizures in the rat.
Neororeport 2004;15:1585—9.
36. Rebola N, Porciuncula LO, Lopes LV, Oliveira CR, Soares-da-
Silva P, Cunha RA. Long-term effect of convulsive behavior on
the density of adenosine A1 and A2A receptors in the rat
cerebral cortex. Epilepsia 2005;46:159—65.
37. Cunha RA. Adenosine as a neuromodulator and as a homeo-
static regulator in the nervous system: different roles, dif-
ferent sources and different receptors. Neurochem Int
2001;38:107—25.
38. Lopes LV, Cunha RA, Kull B, Fredholm BB, Ribeiro JA. Ade-
nosine A2A receptor facilitation of hippocampal synaptic
transmission is dependent on tonic A1 receptor inhibition.
Neuroscience 2002;112:319—29.
39. Rebola N, Sebastiao AM, de Mendonca A, Oliveira CR, Ribeiro
JA, Cunha RA. Enhanced adenosine A2A receptor facilitation
of synaptic transmission in the hippocampus of aged rats. J
Neurophysiol 2003;90:1295—303.
40. Sebastia˜o AM, Ribeiro JA. Fine-tuning neuromodulation by
adenosine. Trends Pharmacol Sci 2000;21:341—6.
41. Pourgholami MH, Mirnajafi-Zadeh J, Behzadi J. Effect of
intraperitoneal and intrahippocampal (CA1) 2-chloroadeno-
sine in amygdaloid kindled rats. Brain Res 1997;751:259—64.
42. Lopes LV, Cunha RA, Ribeiro JA. Cross talk between A1 and A2A
adenosine receptors in the hippocampus and cortex of young
adult and old rats. J Neurophysiol 1999;82:3196—203.
43. Dunwiddie TW, Adenosine and suppression of seizures.Del-
gado-Escueta AV, Wilson WA, Olsen RW, Porter RJ, editors.
Jasper’s basic mechanisms of the epilepsy, vol. 79. Phila-
delphia: Lippincott; 1999. p. 1001—10.
44. Kostopoulos G, Drapeau C, Avoli M, Olivier A, Villemeure JG.
Endogenous adenosine can reduce epileptiform activity in
the human epileptogenic cortex maintained in vitro. Neu-
rosci Lett 1989;106:119—24.
